Sorrento Therpt (NQ: SRNE )
10.50
USD
+1.07
(+11.35%)
Streaming Delayed Price
Updated: 5:27 AM EST, Jan 20, 2021
Add to My Watchlist
Press releases about Sorrento Therpt
From PR Newswire
Conkwest, Sorrento And NantWorks Announce Presentation At The 33rd Annual J. P. Morgan Healthcare Conference By Dr. Patrick Soon-Shiong
January 06, 2015
From PR Newswire
Sorrento To Present At The 2015 Biotech Showcase And 8th Annual OneMedForum In San Francisco
January 05, 2015
From PR Newswire
Conkwest Appoints Robert Rosen and Henry Ji to its Board of Directors
December 29, 2014
Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board
December 24, 2014
From PR Newswire
Sorrento and Conkwest Announce Exclusive Global Collaboration
December 18, 2014
From PR Newswire
Sorrento Announces Strategic Investment By And Collaboration With Nantworks Founder Dr. Patrick Soon-Shiong For The Advancement Of Cancer Immunotherapies
December 15, 2014
From PR Newswire
From PR Newswire
Sorrento To Present At The 2014 Oppenheimer Healthcare Conference
December 03, 2014
From PR Newswire
Sorrento To Present At The 2014 Stifel Healthcare Conference
November 12, 2014
From PR Newswire
BTV Episode #300 Featuring Gilead, Cynapsus and biOasis
November 05, 2014
BTV Episode #300 Featuring Gilead, Cynapsus and biOasis
November 05, 2014
From Marketwired
Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel
October 14, 2014
From PR Newswire
Sorrento and Lee's Pharmaceutical Enter into Exclusive China Licensing Agreement to Develop and Commercialize Anti-PD-L1 antibody
October 03, 2014
From PR Newswire
Sorrento Therapeutics to Present at Two Healthcare Conferences
September 05, 2014
From PR Newswire
Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF)
August 26, 2014
From PR Newswire
Data Published by Researchers from The Scripps Research Institute Demonstrate Potential for MYC Inhibitor Licensed by Sorrento Therapeutics
August 18, 2014
From PR Newswire
From PR Newswire
From PR Newswire
Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor
July 21, 2014
From PR Newswire
San Diego Sleeper Fast-Tracked for FDA Approval
July 07, 2014
From PR Newswire
BTV Reports on Roche, Sorrento Therapeutics Takes on a Goliath, Plus Biotech Up-and-Comers
June 25, 2014
From Marketwired
From PR Newswire
From PR Newswire
Sorrento to Present at BIO Business Forum
June 20, 2014
From PR Newswire
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.